Sanderling Venture Partners VI LP

CIK 1306717 · last filed 2024-11-05

Sanderling Venture Partners VI LP is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing shows the insider bought $3.0M of SCPH on Nov 5, 2024. Across all open-market trades the lifetime net is −$128.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$11.51M

Companies

2

Total Filings

4

Lifetime Open-Market Net

-$128.21M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CalciMedica, Inc. (SCPH) Delisted 10%+ Owner 1,761,044 $5.67 $9.99M $2.96M 1 2024-11-05
PCRX Director 500,672 $22.99 $11.51M -$131.17M 3 2013-03-20

Recent Filings

4 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-11-05 CalciMedica, Inc. (SCPH) Delisted Buy (P) +789,696 $2.96M EDGAR
2013-03-20 PCRX Mixed −2,549,202 -$42.31M EDGAR
2013-03-11 PCRX Mixed −1,181,920 -$38.89M EDGAR
2013-01-25 PCRX Mixed −2,992,980 -$47.33M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.